FDA to ease access to Plan B contraception.
While the agency had until late May to appeal the decision, FDA officials said in an April statement they would not appeal. FDA also sent a letter informing Plan B manufacturer Duramed Research Inc. that the company may, after approval of an application, market Plan B without a prescription to women ages 17 and older.
The Center for Reproductive Rights sued FDA in 2005 for failing to grant over-the-counter status to Plan B, also known as the "morning-after pill," against the advice of its own scientific experts. FDA's April statement said allowing Plan B to be marketed without a prescription was both consistent with the court's order and "consistent with the scientific findings since 2005 by the Center for Drug Evaluation and Research."
The decision was also lauded by the American College of Obstetricians and Gynecologists. If taken within 72 hours, emergency contraception is highly effective in preventing pregnancy and is most effective if taken within 24 hours.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||NATION IN BRIEF|
|Publication:||The Nation's Health|
|Date:||Jun 1, 2009|
|Previous Article:||Healthy Monday helps Americans get back on track: Monday described as 'The Day All Health Breaks Loose'.|
|Next Article:||Ethanol use upping food stamp cost.|